HOME
ABOUT US
OUR TEAM
CLINICAL INDICATIONS
Glioblastoma Multiforme
Soft Tissue Tumors
PIPELINE
FAQ
RESOURCES
OUR PUBLICATIONS
CONTACT
More
Use tab to navigate through the menu items.
Pipeline
Monotherapy Novel NDV strain RY-1 expressing transgenes
Discovery
preclinical phase
phase 1
phase 2
phase 3
Monotherapy Novel NDV strain RY-2 expressing transgenes
Discovery
preclinical phase
phase 1
phase 2
phase 3
Monotherapy Novel NDV strain RY-3 expressing transgenes
Discovery
preclinical phase
phase 1
phase 2
phase 3
Combined with Immunotherapy
Discovery
preclinical phase
phase 1
phase 2
phase 3